Citi downgrades Moderna to sell, sees 60% downside
Citi analyst Geoff Meacham downgraded Moderna to sell with a price target of $80, implying a 60% drop from Tuesday's closing price.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.